Related Experiment Video
Updated: Jun 12, 2026

Monitoring Protein Aggregation Kinetics In Vivo using Automated Inclusion Counting in Caenorhabditis elegans
Published on: December 17, 2021
Current understanding on the pathogenesis of polyglutamine diseases
Xiao-Hui He1, Fang Lin, Zheng-Hong Qin
1Department of Pharmacology and Laboratory of Aging and Nervous Diseases, Soochow University School of Medicine, Suzhou 215123, China.
Polyglutamine (polyQ) diseases stem from expanded CAG repeats, leading to protein misfolding and neurodegeneration. This review explores common pathogenic mechanisms, including protein conformational changes and impaired proteolysis, in these debilitating conditions.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Polyglutamine (polyQ) diseases are a class of neurodegenerative disorders characterized by the expansion of CAG trinucleotide repeats in specific genes.
- These expanded repeats lead to the production of proteins with abnormally long polyglutamine tracts, causing cellular dysfunction.
Purpose of the Study:
- To review the common pathogenic mechanisms underlying various polyglutamine diseases.
- To elucidate the relationship between protein misfolding, proteolysis, and selective neuronal death in these disorders.
Main Methods:
- This review synthesizes existing research on the molecular pathogenesis of polyglutamine diseases.
- Focuses on protein conformational changes, proteolysis, and gene expression patterns.
Main Results:
- Expanded polyQ tracts induce protein misfolding and conformational changes, impacting protein function.
- Decreased proteolysis correlates with the late onset of polyQ diseases.
- Widespread expression of disease-associated proteins contributes to selective neuronal vulnerability.
Conclusions:
- Understanding these shared pathogenic pathways is crucial for developing therapeutic strategies for polyglutamine diseases.
- Targeting protein misfolding, enhancing proteolysis, and addressing selective neuronal death are potential therapeutic avenues.
Related Concept Videos
Parkinson Disease ll: Pathophysiology
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Huntington Disease l: Introduction

